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Abstract
Background: Inhalation of N-chlorotaurine (NCT), an endogenous new broad spectrum non-antibiotic anti-
infective, has been shown to be very well tolerated in the pig model recently. In the present study, inhaled NCT
was tested for tolerability and efficacy in the infected bronchopulmonary system using the same model.
Methods: Anesthetized pigs were inoculated with 20 ml of a solution containing approximately 10
8 CFU/ml
Streptococcus pyogenes strain d68 via a duodenal tube placed through the tracheal tube down to the carina. Two
hours later, 5 ml of 1% NCT aqueous solution (test group, n = 15) or 5 ml of 0.9% NaCl (control group, n = 16)
was inhaled via the tracheal tube connected to a nebulizer. Inhalation was repeated every hour, four times in total.
Lung function and haemodynamics were monitored. Bronchoalveolar lavage samples were removed for
determination of colony forming units (CFU), and lung samples for histology.
Results: Arterial pressure of oxygen (PaO2) decreased rapidly after instillation of the bacteria in all animals and
showed only a slight further decrease at the end of the experiment without a difference between both groups.
Pulmonary artery pressure increased to a peak 1-1.5 h after application of the bacteria, decreased in the following
hour and remained constant during treatment, again similarly in both groups. Histology demonstrated granulocytic
infiltration in the central parts of the lung, while this was absent in the periphery. Expression of TNF-alpha, IL-8,
and haemoxygenase-1 in lung biopsies was similar in both groups. CFU counts in bronchoalveolar lavage came to
170 (10; 1388) CFU/ml (median and 25 and 75 percentiles) for the NCT treated pigs, and to 250 (10; 5.5 × 10
5)
CFU/ml for NaCl treated pigs (p = 0.4159).
Conclusions: Inhaled NCT at a concentration of 1% proved to be very well tolerated also in the infected
bronchopulmonary system. This study confirms the tolerability in this delicate body region, which has been proven
in healthy pigs previously. Regarding efficacy, no conclusions can be drawn, mainly because of the limited test
period of the model.
Background
N-chlorotaurine is an endogenous mild oxidant formed
from hypochlorous acid and taurine during the oxidative
burst of granulocytes and monocytes [1,2]. It can be
synthesized chemically as sodium salt (Cl-HN-CH2-CH2-
SO3-Na, NCT) [3] and has been applied successfully as a
new broad spectrum non-antibiotic anti-infective in clini-
cal studies to different body sites [4], for instance the eye
[5], the outer ear [6], and skin ulcerations [7]. Because of
its high tolerability, also susceptible regions come into
question for topical therapy. Recently, inhaled NCT at a
concentration of 1% (w/v) in water was very well toler-
ated in a pig model [8]. Compared to 0.9% sodium chlor-
ide (w/v), no worsening of oxygenation parameters (e.g.
arterial pressure of oxygen, alveolo-arterial difference of
oxygen partial pressure) and pulmonary artery pressure
could be found. There were no differences in histology of
lung samples between 1% NCT and 0.9% NaCl, and
the surfactant function was not impaired by 1% NCT [8].
A five times higher NCT concentration (5%) led to
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further measureable disorders.
Based on these findings, in the present study we wanted
to investigate the effects of inhaled 1% NCT to the bronch-
opulmonary system of pigs whose airways had previously
been infected with Streptococcus pyogenes. In addition, we
attempted to test the efficacy of NCT, being aware of the
limited observation time possible in this pig model.
Methods
Test solutions
Pure NCT as a crystalline sodium salt (molecular weight
181.57) was prepared according to [3]. Purity was proved
by spectrophotometry [3]. NCT was dissolved in sterile
and pyrogen-free distilled water to solutions with a final
concentration of 1% (w/v; 55 mM). Solutions were sterile-
filtered and stored at 2-4°C for maximally one week. Ster-
ile and pyrogen-free 0.9% sodium chloride (B. Braun
Melsungen AG, Melsungen, Germany) was used as a con-
trol. To warrant double-blinding, test and control solu-
tions were filled in similar flasks. All flasks were numbered
consecutively in accordance with the randomization code.
Animals
The experiment was approved by the Austrian Federal
Animal Investigational Committee, and animals were
managed in accordance with the National Institutes of
Health guidelines http://grants.nih.gov/grants/olaw/olaw.
htm. Healthy, 4-week-old white farm pigs were used in
the study. They were anesthetized during the whole
experiment.
Bacteria
Streptococcus pyogenes d68, kindly provided by J. Hildeb-
randt, Sandoz Scientific Center Vienna [9], deep frozen for
storage was grown on Columbia agar with 5% (v/v) sheep
blood. The strain was chosen because of its high virulence
proven in a mouse model [9], since we aimed to cause
rapid inflammation due to the limited test period of the
pig model. Single colonies from the agar plates were
grown at 37°C for 14-15 h in 20 ml tryptic soy broth
(Merck) without agitation. Subsequently, the suspension
was centrifuged for 10 min at 1800 × g, and the bacteria
were washed twice with 0.9% NaCl before application.
Colony forming units (CFU) counts were determined by
spreading 50 μL aliquots of adequate dilutions in duplicate
onto blood agar with an automated spiral plater (model
WASP 2, Don Whitley Scientific Limited, Shipley, UK).
T h ep l a t e sw e r ei n c u b a t e da t3 7 ° C ,a n dt h eC F Uw e r e
counted after 24 and 48 h.
Study design and treatment
The pigs were randomly assigned to the test group (4
inhalations with 5 ml 1% NCT) or to the control group
(4 inhalations with 5 ml 0.9% NaCl). Sixteen animals
per group were included. One animal of the NCT group
demonstrated a very bad lung and circulation function
after anaesthesia and was excluded from the study so
that finally 15 pigs received full treatment and were
evaluated in the test group compared to 16 in the con-
trol group. Maximally two pigs were treated and evalu-
ated on the same day. Application of test solutions and
measurements of evaluation parameters were performed
in a blinded way. Thirty min after anesthesia, baseline
parameters were recorded (criteria for baseline: arterial
pH between 7.35 and 7.40, pCO2 between 35 and
40 mmHg, pO2 at least 80 mmHg). Then, a solution of
20 ml containing 0.5 - 5.0 × 10
8 CFU/ml S. pyogenes
d68 with no difference between the test and control
group was instilled via the endotracheal tube (ID 6,0
Lo-Contour Murphy, Mallinckrodt, Ireland).
120 min later, the first inhalation was performed, fol-
lowed by three further inhalations at intervals of 60 min
with 5 ml of 1% NCT or 0.9% NaCl. Approximately thirty
min after the last inhalation, the animals were euthanized,
a bronchoalveolar lavage (BAL) with 10 ml of 0.9% NaCl
in each lung was performed, and lung samples were
removed. Parameters of oxygenation and circulation were
monitored. Baseline values and values every 30 min after
the first inhalation were recorded. Blood samples were
taken every 30 min, arterial and expiratory multiple inert
gas elimination technique was performed at baseline,
before first inhalation, 30 min, 120 min and 240 min after
the first inhalation. Blood samples for quantifying serum
taurine and chloride levels were taken at baseline and at
the end of the experiment.
Anaesthesia of pigs
Anaesthesia was induced with ketamine (25 mg/kg IM)
and azaperone (2 mg/kg IM), followed by intravenous
propofol (1-2 mg/kg IV). After the trachea had been intu-
bated, piritramide 15 mg was administered. Anaesthesia
was then maintained with propofol (10 - 15 mg kg
-1 h
-1)
and piritramide boluses (7.5 mg each, summary dosis of
1.65 mg/kg). Ringers solution (14 ml kg
-1 h
-1), 0.9% NaCl
(20 ml kg
-1 h
-1) and a 4% gelatine solution (6 ml kg
-1 h
-1)
were administered throughout the procedure. Lungs
were ventilated in a volume controlled mode (Evita 2,
Dräger Medical, Vienna, Austria) at an inspiratory frac-
tion of oxygen (FIO2) of 0.21 and a tidal volume (VT) of
10 - 12 ml/kg at 15 breaths/min, positive end expiratory
pressure set at 5 cm H2O. Tidal volume was then
adjusted to achieve an arterial pressure of carbon dioxide
(PaCO2) between 35 and 40 mmHg, resulting in an aver-
age min volume of 180 ml kg
-1 min
-1. A standard lead II
ECG was used to monitor cardiac rhythm. Body tempera-
ture was maintained between 38°C and 39°C using an
electric heating blanket.
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Two venous catheters were inserted percutaneously into
auricular veins for inert gas infusion and continuous infu-
sion of propofol. A no. 7F thermistor-tipped Swan-Ganz
catheter (Baxter Edwards, Irvine, CA) was inserted into
the right jugular vein and advanced into a main pulmon-
ary artery by use of direct-pressure monitoring. This
allowed measurement of cardiac output, mean pulmonary
arterial pressure (PAPM), pulmonary artery occlusion
pressure (PCWP) and mixed venous blood sampling. The
left femoral artery was cannulated with a no. 6F Avanti+
introducer (length 11 cm, Cordis Corporation, Miami,
USA) for measurement of systemic pressure and arterial
blood sampling. The urine volume was measured with a
balloon catheter (Rüsch Brillant Silicone Catheter, Teleflex
Medical, Kamunting, Malaysia).
Haemodynamic measurements
Systolic, diastolic and mean arterial and pulmonary arterial
pressure (SAP, DAP, MAP; PAP, sPAP, dPAP, mPAP),
central venous pressure (CVP) and pulmonary artery
occlusion pressure (PCWP) were measured with an ICU
monitor (Datex AS/3, Sanitas, Salzburg, Austria) with
standard pressure transducers (single transducer set no.
REF 686685, model PM SET 1DT-XX 1 Rose, Becton
Dickinson Critical Care Systems, Singapore) that had been
zeroed to the level of the right atrium. Cardiac output was
measured with an Inline Injektat Sensor (set no. REF
1900210, Angiokard Medizintechnik GmbH + CoKg, Frie-
deburg, Germany) and a no. 7 Swan-Ganz catheter
(Edwards Lifesciences Austria GmbH, Vienna, Austria).
The mean of 3 determinations of cardiac output was
recorded.
Blood Gas and Metabolic Measurements
Arterial and mixed venous samples (2 ml each) were col-
lected simultaneously and immediately analyzed for oxy-
gen and carbon dioxid partial pressure, pH, haemoglobin
concentration, haematocrit, and electrolytes with a Bayer
Rapidlab 865 blood gas analyzer (Bayer Healthcare, Fern-
wald, Germany).
Respiratory Measurements
Airway pressures, expiratory tidal volume, expiratory min
volume, and respiratory rate values were recorded by the
built-in detectors of the ventilator. Ventilation-perfusion
distributions were determined using the multiple inert gas
elimination technique (MIGET, 5890 Series II Gas Chro-
matograph, Hewlett Packard Company, Wilmington, USA
[10,11]).
Inoculation and NCT treatment protocol
After instrumentation of the animals and a stabilization
period of 30 min, baseline measurements (haemodynamics,
ventilation parameters, blood gases, MIGET) were
performed. Then, the suspension of 20 ml containing
S. pyogenes d68 was instilled via the endotracheal tube.
Two hours later we performed the first inhalation with an
ultrasonic nebulizer (Optineb
®-K Mobile Ultrasonic Nebu-
lizer ON-100/5 2,4 MHz from NEBU-TEC med. Produkte,
Elsenfeld, Germany). The Mass Median Aerodynamic
Diameter of the particles produced by this nebulizer was
2.3 μm, which warranted sufficient penetration of the
NCT-containing aerosol to the bronchioli and alveoli.
Delivery of the aerosol was provided during the inspiration
phase by direct connection to the inspiratory side of the
Y-piece. At the end of the experimental runs, animals were
killed using potassium chloride in conjunction with a dee-
pening of the general anaesthesia.
Quantification of S. pyogenes in bronchoalveolar fluid
Immediately after euthanizing the animals, the chest was
opened and a peripheral bronchus was irrigated with
10 ml of 0.9% NaCl. Undiluted bronchial fluid as well as
aliquots of this fluid tenfold diluted in 0.9% NaCl (50 μl
each) were spread in duplicate on blood agar plates with
the automatic spiral plater, and CFU were counted after
incubation at 37°C for 24 h and 48 h. S. pyogenes was dif-
ferentiated by the mucous colony form from other bac-
teria. Other bacterial species growing on the plates were
counted separately. All bacterial species were identified
biochemically (Vitek
®, BioMerieux, Mary l’Etoile, France).
Pharmacokinetics of NCT
To address the local pharmacokinetics in the lung, 5 ml
of the bronchoalveolar fluid (see previous paragraph)
were removed, potassium iodide was added in excess,
and the formed coloured tri-iodide was measured spec-
trophotometrically at 350 nm, its maximum wavelength
(absorption coefficient 22900 mol
-1 cm
-1 [12]).
To address systemic uptake of NCT, the taurine con-
centration in the serum was determined at the baseline
and after the last inhalation in 5 samples of the test and
6 samples of the control group. If NCT in amounts used
for inhalation comes into contact with blood, it is imme-
diately inactivated by thio groups and degrades into taur-
ine and chloride. Therefore, taurine is an ideal measure
for systemic uptake of topically applied NCT. Taurine
was analyzed by ion-exchange chromatography with nin-
hydrin detection (AminoTac, JLC-500/V, Jeol) [13,14].
The disulfide cystine as an oxidation product of cysteine
and methionine were evaluated, too.
Histology
Subsequent to euthanizing the animal, artificial ventila-
tion was continued up to removal of lung samples of the
upper and lower lobes taken from both a central and a
peripheral area. Lung tissue was subjected to histological
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lin fixation (buffered 4% formalin, v/v) and paraffin-
embedding.
Moreover, fresh tissue was used to extract protein, DNA
and RNA according to commercial kits instructions. The
tissue was routinely stained with haematoxylin and eosin,
periodic acid Schiff (glycogen staining), elastica van Gieson
(elastic fibers of the intrapulmonary blood vessels), and
reticulin (reticulin fibers). Haematoxylin-eosin staining
was used to evaluate the infiltration with neutrophilic
granulocytes, eosinophilic granulocytes, lymphocytes,
erythrocytes, atelectasis, bronchiolitis, bronchitis, lym-
phangiectasia, and capillary congestion. PAS staining was
used to evaluate the variability of the amount of goblet
cells, mucus, detachment of epithelial cells and epithelial
changes. Elastica van Gieson staining was used to detect
the fragmentation of the external and internal laminae of
the blood vessels. Reticulin staining was used to detect col-
lapse of fibers, thinning or thickening of the alveolar septa,
the presence of emphysema, bullae and thickening of the
pleura.
In situ determination of cytokines
Expression of interleukin (IL)-8, tumor necrosis factor
alpha (TNF-alpha), and haemoxygenase 1 (HO-1) was
investigated by mRNA analysis according to [15]. Real-
time RT-PCR was performed as described in detail in our
previous study on biopsies collected in RNAlater (Ambion,
Austin, TX, USA) and stored at minus 80°C until analysis
[8]. Briefly, tissue was disrupted by 3 to 4 runs with the
RiboLyser (ThermoHYBAID, Heidelberg, Germany) in lys-
ing matrix „D” tubes (Q-BIOgen, Heidelberg) containing
400 μl lysis buffer from the MagnaPure mRNA Isolation
Kit II (ROCHE Diagnostics, Mannheim, Germany). Lysate
was mixed with capture buffer containing oligo-dT, centri-
fuged, and transferred into a MagnaPure sample cartridge.
mRNA was isolated with the MagnaPure-LC device using
the mRNA-II standard protocol.
An aliquot of 8.2 μl mRNA was reversely transcribed
using AMV-RT and oligo- (dT) as primer (First Strand
cDNA synthesis kit, Roche) according to the manufactures
protocol in a thermocycler. cDNA samples were stored at
-20°C until PCR analysis. Primer sets for pig GAPDH, IL-
8, HO-1 and TNF-alpha optimized for the LightCycler
®
(RAS, Mannheim, Germany) were developed and pur-
chased from SEARCH-LC GmbH, Heidelberg. The PCR
was performed with the LightCycler
® FastStart DNA Sybr
GreenI kit (RAS) according to the protocol provided in
the parameter specific kits with evaluation specifications
as published previously [8]. To correct for differences in
the content of mRNA, the calculated copy numbers were
normalized according to the average expression of the
housekeeping gene GAPDH. Values were thus given as
input adjusted copy number per μlo fc D N A .
Statistical Analysis
Shapiro-Wilk normality test was applied to test for Gaus-
sian distribution of the data. Accordingly, they are
presented as mean values and standard deviations or stan-
dard errors of the mean or as median and percentiles. For
hemodynamics, blood gas, respiratory measurements,
pharmacokinetic parameters, and HO-1, Student’s
unpaired t test or one-way ANOVA and Bonferroni’sm u l -
tiple comparison test was used to test for a difference
between the test and control group, while the paired t test
was applied to test for differences between different time-
points in each group. Mann-Whitney U test was used to
compare CFU counts of bacteria in bronchoalveolar fluid
and TNF-alpha and IL-8 in lung biopsies. Chi-square and
Fisher’s test were used for evaluation of changes found in
histology. Student’s t test for unpaired samples was applied
for comparison of the number of granulocytes counted by
microscopy in lung histology sections. Calculations were
done with GraphPad Prism 5 software. P < 0.05 was con-
sidered significant for all tests.
Results
Pulmonary gas exchange
Arterial partial pressure of oxygen (PaO2)v a l u e sa tt h e
beginning of anaesthesia were within normal range in all
animals without any intergroup difference (90.1 ± 5.9
mmHg and 92.4 ± 7.8 mmHg, test versus control animals),
reflecting healthy, anesthetized and ventilated animals.
After application of streptococci via the respiration tube,
PaO2 decreased rapidly within 30 min to 75.9 ± 7.3 and 82
± 5.6 mmHg, respectively (Figure 1, p < 0.01 versus base-
line for both groups). At the beginning of the inhalations,
the values were 77.9 ± 10.3 and 81.2 ± 6.0 mmHg. PaO2
remained constant over the inhalation period in all ani-
mals and was 75.6 ± 11.8 and 76.5 ± 13.2 mmHg, respec-
tively, 4 hours later (p > 0.1 between groups and over that
time).
Alveolo-arterial difference of oxygen partial pressure
(AaDO2) increased from 22.2 ± 13.3 mmHg (17.8 ± 8.6
for controls) at the baseline to 32.5 ± 9.4 mmHg (31.2 ±
7.0) at the beginning of the inhalations, and to 39.8 ±
12.5 mmHg (41.2 ± 11.5) at the end of the experiment
(p > 0.1 between NCT and NaCl; p < 0.05 between these
time points in each group). Arterial oxygen saturation
remained constant between 94% and 97% in all animals.
A slight increase of the pH from about 7.47 to 7.51 (p <
0.05 for the change over time from the beginning to the
end of the inhalations, but p > 0.05 between groups) and
an according slight decrease of the arterial carbon diox-
ide pressure from about 36.2 to 32.5 mmHg was moni-
tored. Ventilation-perfusion distributions determined
with MIGET showed no differences between the test
(normal VA/Q of Q ratio after 4 hours 96% for 1% NCT)
and control groups (97%).
Schwienbacher et al. BMC Infectious Diseases 2011, 11:231
http://www.biomedcentral.com/1471-2334/11/231
Page 4 of 9Haemodynamics
Pulmonary artery pressure increased during the first 1.5
h after challenge with bacteria (p < 0.01), decreased
again in the following hour and remained constant dur-
ing the inhalation period (Figure 2). It seemed to
decrease again to lower values in the control than in the
test group, but the difference was not significant (p =
0.077 and 0.095 for 4 and 4.5 h, respectively, and p >
0.1 for all other time-points).
No differences between the test and control group
were found in further haemodynamics (p > 0.05 for all
parameters). Heart rate increased from 81 ± 16/min
( t e s tg r o u p )a n d7 6±1 1 / m i n( c o n t r o lg r o u p )a tt h e
baseline to 92 ± 17 and 86 ± 11 at the beginning of the
inhalations 2 h later (p < 0.01), and to 104 ± 20/min in
both groups after 6 h (p < 0.05). Systolic blood pressure
increased from 120 ± 17 and 115 ± 12 at the baseline to
147 ± 23 and 147 ± 20, respectively, after 2 h (p < 0.01)
and decreased again slowly during the inhalation period
(136 ± 12 and 140 ± 14 after 6 h; p = 0.03 and 0.06,
respectively). Diastolic blood pressure behaved in a simi-
lar way, i.e. increased from 70 ± 15 and 68 ± 12 to 99 ±
20 and 101 ± 15 after 2 h (p < 0.01 for both), and came
to 90 ± 16 (p < 0.05) and 94 ± 17 (p > 0.05) after 6 h.
No notable changes were found in central venous pres-
sure and pulmonary capillary wedge pressure.
Microbiology
From BAL performed immediately after euthanasia and
opening of the chest, S. pyogenes d68 could be cultivated
in 13 of 15 animals in the NCT group and in 12 of 16 ani-
mals in the control group. The median and percentiles of
S. pyogenes CFU found in quantitative cultures are
depicted in Figure 3. The median (25; 75 percentile) was
170 (10; 1388) CFU/ml for the NCT treated pigs with a
range of 0 to 7900, and 250 (10; 7500) CFU/ml for NaCl
treated pigs with a range of 0 to 12500 and one outlier of
5.5 × 10
5. There was no difference between both groups
with p = 0.4159 (Mann-Whitney U test).
In addition, the total bacterial count of all species that
were found on the plates was determined. Additional spe-
cies were mainly Pseudomonas aeruginosa, Streptococcus
suis,a n dStaphylococcus aureus, which were not instilled
via the respiratory tube. The median (25; 75 percentile)
was 1710 (276; 7284) CFU/ml for the NCT treated pigs
with a range of 150 to 22300, and 3000 (710; 10350) CFU/
ml for NaCl treated pigs with a range of 50 to 5.5 × 10
5.
0 1 2 3 4 5 6
55
65
75
85
95
105
0.9% NaCl
1% NCT
Application
of bacteria
Inhalation period
*
h
P
a
O
2
 
(
m
m
H
g
)
Figure 1 Arterial partial pressure of oxygen (PaO2) of the pigs
during the inhalation period. Mean values ± SEM of 15 (NCT) and
16 (NaCl) animals. * p < 0.05 between NCT and NaCl; p > 0.05
between NCT and NaCl for all other time-points (unpaired t test);
p < 0.01 between time zero and all other time-points (paired t test).
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Figure 2 Mean pulmonary artery pressure (mPAP) of the pigs
during the inhalation period. Mean values ± SEM of 15 (NCT) and
16 (NaCl) animals. P > 0.05 between NaCl and 1% NCT for each
time-point (unpaired t test); * p < 0.05 versus baseline (paired
t test); ** p < 0.01 versus baseline (paired t test).
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Figure 3 Counts of CFU of S. pyogenes d68 in bronchoalveolar
fluid after 4 inhalations. Median and 10-90 percentiles of 15 (NCT)
and 16 (NaCl) pigs; p = 0.4159.
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p = 0.2599.
Pharmacokinetics
In bronchoalveolar fluid, no oxidative capacity could be
found approximately 30 min after the last inhalation.
Taurine levels in serum were 55.0 ± 27.1 μmol/l for
NCT and 52.3 ± 22.4 μmol/l for NaCl (p > 0.1) at time
zero, and 45.5 ± 25.2 μmol/l for NCT and 45.8 ± 20.1
μmol/l for NaCl (p > 0.1) after the last inhalation (mean
values ± SD; n = 5 for NCT and n = 6 for NaCl).
Cystine levels came to 10.2 ± 9.1 μmol/l for NCT and
7.9 ± 4.4 μmol/l for NaCl (p > 0.1) at time zero, and
17.0 ± 7.9 μmol/l for NCT and 13.4 ± 3.7 μmol/l for
NaCl (p > 0.1) after the last inhalation. The values for
methionine were 19.3 ± 4.0 μmol/l for NCT and 16.6 ±
5.1 μm o l / lf o rN a C l( p>0 . 1 )a tt i m ez e r o ,a n d2 3 . 2±
7.0 μmol/l for NCT and 26.3 ± 8.7 μmol/l for NaCl
after the last inhalation (p > 0.1). The increase of cystine
levels after the last inhalation was significant for both
the NCT (p < 0.011) and the NaCl group (p = 0.0001),
whereas there were no differences between the groups.
Histology
In the histological sections, a mild bronchiolitis and
bronchitis was detectable. It was markedly present in
the carina area and moderate in the area distant to car-
ina. In the peripheral area, the inflammation was less
significant. In the upper lung lobes, no inflammation
was found.
Examination of the different lung fields using a random
number generator and ImageJ as well as manual counting
mostly identified two different histologic patterns. In the
first one, there were lung fields that showed no inflamma-
tion or many clear areas with leukocytic infiltration mar-
ginalized to some bronchial lumina and very few
leukocytes in single alveoli (Figure 4a-b). This pattern was
present in 12 out of 15 pigs in the NCT group and in 13
out of 16 pigs in the control group (p > 0.1). In the second
pattern, leukocytic infiltration was diffuse involving both
the bronchial and alveolar systems, represented in 3 pigs
of the NCT and in 2 pigs of the control group (p > 0.1).
Both patterns showed a mild increase of the thickness of
the bronchial wall (Figure 4c). However, this finding was
patchy in the same lung and not uniform between the ani-
mals (p > 0.1 between both groups). No inflammation at
all could be found in few specimens (1 in the NCT, 3 in
the NaCl group, p > 0.1) (Figure 4d), whilst a few cases
showed mostly clear areas with focal infiltration with poly-
morphonuclear leukocytes in bronchial lumina (8 in the
test, 5 in the control animals, p > 0.1). Moreover, there
were multinucleated giant cells in a single case in each
group. Plasmacellular infiltration was found in 1 pig of the
NCT group, and macrophage involvement in 5 of the test
and in 2 of the control pigs (p > 0.1). Granulocytes were
counted in three microscopic fields of at least two samples
per animals at a 400-fold magnitude, and the numbers
came to 51.1 ± 68.5 per field (mean value ± SD; range 0 -
321) for test samples and to 35.2 ± 64.8 per field (mean
value ± SD, range 0 - 345) for controls (p > 0.1).
In situ determination of cytokines
Biopsies near the carina from 10 animals of the NCT
group and 8 animals from the control group were ran-
domly selected and analyzed. The adjusted transcript
values (number/μl cDNA) are listed in Table 1. The
expression of the investigated genes was less variable than
in the tolerability study [8], but the absolute values were
higher. There were no differences between the test and
control group (p > 0.6).
Discussion
Recently, the pig model proved to be very suitable and
sensitive to test the tolerability of inhaled NCT [8]. In the
present study, we tested if the concentration of 1% NCT,
which was well tolerated in the healthy pig, was also tol-
erable in the infected lung.
Oxygenation (e.g. pressure of oxygen) and hemodynamic
(e.g. pulmonary artery pressure) measures worsened
quickly in the present study after bronchial application of
the bacteria, but they remained either constant during the
inhalation period or worsened moderately without a differ-
ence between the test and control group. This course indi-
cates that S. pyogenes had a rapid impact on the lung
function in the first 1-2 hours, i.e. before the inhalations
were started. Previous studies using similar pig models are
in compliance with this finding, since a rapid decrease of
PaO2 was detected after bronchial application of P. aerugi-
nosa [16,17] and Group B streptococci [18]. Increased
respiratory rate was seen in pigs challenged with Actinoba-
cillus pleuropneumoniae [19,20]. The absence of a marked
worsening in the following time in our study suggests that
the bacteria did not cause a massive, life-threatening
inflammation in the first 6 hours after the challenge, simi-
lar to the just mentioned previous studies [16-20]. This is
supported by the histological findings of partial leukocyte
infiltration in the central parts of the lung, which indeed
had been observed in a similar percentage of 60 - 70% of
the pigs in the previous tolerability study in healthy pigs,
t o o[ 8 ] .T h e r e f o r e ,i tr e m a i n su n c l e a rt ow h a te x t e n tt h e
bacteria contributed to the histologically visible inflamma-
tion. In any case, their influence on the clinical parameters
was obvious. Moreover, transcript values of IL-8, TNF-
alpha, and HO-1 were equal in the NCT and NaCl group,
but higher than in the previous pig inhalation study,
where no bacteria were applied [8]. This clearly indicates
that these elevated levels were caused by the streptococci
and not by NCT.
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ated blood gas, haemodynamic, and histological para-
meters were similar in the test and control group,
inhaled 1% NCT proved to be well tolerated in the
infected pig lung, too. The mean pulmonary artery pres-
sure values appeared to be a little higher in the test
group (Figure 2). However, this difference did not reach
statistical significance at any time point. Moreover, the
pressure increased to higher levels in the test than in
the control group already after instillation of the bac-
teria and before the beginning of the inhalations. Similar
to the controls, it decreased after the first inhalation,
and approximated again to the value of the controls
Table 1 Gene expression by qRT-PCR in lung samples
after inhalation, adjusted mRNA transcript values
(number/μl cDNA)
1% NCT 0.9% NaCl
HO-1
a 7458 7450
(2823) (4673)
TNF- alpha
b 1291 1101
(767; 2568) (590; 4600)
IL-8
b 1859 1188
(933; 20214) (771; 6695)
a mean values and (SD)
b median and (25%; 75% percentiles)
p > 0.6 between NCT and NaCl for all values.
a  b 
c  d 
*
Figure 4 Histological evaluation of lung samples. Figure 4a-b show lung tissue from a pig treated with NCT showing atelectases (*) and
infiltration of the bronchial and alveolar system by neutrophilic granulocytes that are present in the lumen of a bronchial airway (arrows)
(hematoxylin-eosin staining; original magnification 100× (a) and 400 × (b); p > 0.1 for frequency of occurrence between test and control group).
Figure 4c shows a mild increase of thickness of the bronchial wall on serial sections, although this finding was patchy in the same lung and not
uniform in the same group (arrow) (hematoxylin-eosin staining; original magnification 200×). Figure 4d shows lung tissue from a pig treated
with NaCl showing neither atelectasis nor neutrophilic granulocytic infiltration (hematoxylin-eosin staining, original magnification 50x; p > 0.1 for
frequency of occurrence between test and control group).
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Page 7 of 9after 4 inhalations. Because of all these reasons, we esti-
mate these findings as no difference in pulmonary artery
pressure between test and control group. Furthermore,
this conclusion is in agreement with the previous study
in healthy pigs [8].
It is true that the observation period of six hours after
application of the bacteria was limited, but prolongation
of the anaesthesia of the pigs for a few days as in few pre-
vious studies [16,17] has not been possible in our unit.
While this - in all likelihood - did not impact the testing
of the tolerability of NCT, a reliable evaluation of its effi-
cacy turned out to be impossible within that observation
period. Actually, development of pneumonia with severe
clinical signs and increase of markers of inflammation in
the blood needed at least 12-24 h after bronchial inocula-
tion of P. aeruginosa [16,17] or inhalation of nebulized
A. pleuropneumoniae [19,20]. We tried to overcome this
problem in part using S. pyogenes d68, a strain highly
virulent at least in the mouse [9], but we were not suc-
cessful to induce a massive inflammation within short
time. The high range of CFU counts in BAL indicates a
randomly scattered distribution of bacteria in the bron-
chial system, which fitted well to the different histological
findings in samples from different areas. Application of
bacteria in a nebulized form may lead to a more equal
distribution, but this was not possible with a highly viru-
lent strain. As an approach to test this, we applied Micro-
coccus luteus (4-5 ml of 3-4 × 10
8 CFU/ml) through
the nebulizer in four additional pigs, but not more than
1 0C F U / m lc o u l db eg r o w n ,a n d5o f8B A Lc u l t u r e s
were negative.
The absence of oxidative activity in the bronchoalveolar
fluid approximately 30 min after inhalation of 5 ml 1%
NCT confirms the results in healthy pigs [8] and indicates
a short half-life of NCT in the lung. Taking into account
the large surface of the lung, the limited amount of 4 ×
5 ml inhaled and the rapid decay of NCT into taurine and
chloride in the presence of organic substances [21], this
result fits very well to previous knowledge. The short half-
life together with the mild activity of NCT explain also the
absence of a difference in the CFU counts between the
control and test group indicating the absence of a rapid
massive killing of bacteria by NCT. Further reasons may
be the scattered distribution of bacteria (see above) and
also of NCT. One has to be aware that particularly in the
inflamed bronchopulmonary system with the occurrence
of atelectases, distribution of inhaled substances is never
completely homogenous. However, these considerations
do not exclude a therapeutic efficacy. NCT is known to
impact the virulence of pathogens after very short sub-
lethal contact times of 1 min and to exert a postantibiotic
effect [9,22,23], and it has shown efficacy in conjunctivitis
in the human eye despite loss of oxidative activity within a
few min [24,25].
Conclusions
N-chlorotaurine was well tolerated at a concentration of
1% upon inhalation in an acute pig streptococcal lower
airway inflammation model. This study confirms the tol-
erability in this delicate body region, which has been
proven in healthy pigs previously. To evaluate the effi-
cacy of NCT, the model turned out to be not suitable,
mainly because of the limited test period.
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